The ERK, JNK/SAPK and p38/RK MAP kinase subtypes are dierentially activated by physiological, pharmacological and stress stimuli; all three subtypes are implicated in immediate-early (IE) gene induction by these agents. Here, we have asked whether inhibition of a single MAP kinase subtype under these conditions would generally alter induction of several IE genes in a similar way or whether this would dierentially up-and down-regulate particular IE genes, an issue which bears on the question of whether individual MAP kinases are strictly targeted to speci®c IE genes, or whether they might catalyse phosphorylation events that aect several IE genes in the same way. SB 203580, an inhibitor of p38/RK, has been used to analyse the role of this kinase in the induction of ®ve IE genes (c-fos, fosB, c-jun, junB and junD) under diverse conditions of stimulation. In C3H 10T cells, p38/RK and its downstream kinase MAPKAP K-2 are activated by all stimuli used with the exception of TPA. The speci®city of SB 203580 as a p38/RK inhibitor in these cells is demonstrated; it does not aect ERKs or JNK/SAPKs but does result in a small increase in the activity of the upstream kinase MKK6, the principal p38/RK activator in these cells. We ®nd that inhibition of p38/RK under these conditions produces general eects on all ®ve IE genes as a group in three ways. First, induction of all ®ve genes in response to okadaic acid or tumour necrosis factor-a (TNF-a) is not signi®cantly altered by SB 203580. Second, in cells stimulated with anisomycin or U.V. radiation, SB 203580 potently inhibits all of the induced IE genes. Finally, SB 203580 enhances induction of all ®ve IE genes in EGF-treated cells; these enhanced mRNA levels are not due to stabilisation of labile mRNA transcripts. The signi®cance of these results to current thinking on the relationship between distinct MAP kinase subtypes and speci®c IE genes is discussed.
Introduction
Three broad classes of stimuli elicit signalling responses and immediate-early (IE) gene transcription in diverse cell types. These are (i) physiological agents such as growth factors (reviewed in Marshall, 1995) and cytokines (Freshney et al., 1994; Sluss et al., 1994) ; (ii) stresses such as U.V. irradiation (Hibi et al., 1993; Kyriakis et al., 1994; Gupta et al., 1995; Livingstone et al., 1995; van Dam et al., 1995) , chemical and heat shock (Rouse et al., 1994) , and (iii) pharmacological compounds such as TPA , okadaic acid reviewed in Cohen et al., 1990) and anisomycin (Edwards and Mahadevan, 1992; Cano et al., 1995; Hazzalin et al., 1996) . Although there is considerable overlap in the signalling and gene induction responses elicited by these agents, the precise quantitative response of MAP kinase subtypes and individual IE genes appears characteristic for each agent reviewed in Cooper, 1994; Cano and Mahadevan, 1995; Seger and Krebs, 1995) . The only known signalling responses activated in common by all three classes of stimuli are the activation of p70/85
S6k and phosphorylation of S6, the dierential activation of MAP kinase subtypes and the nucleosomal response i.e. the rapid phosphorylation of histone H3 Barratt et al., 1994a) and HMG-14 (Barratt et al., 1994b) on serine residues in their NH-termini . However, p70/85 S6k activation can be ablated with rapamycin with no consequence to nucleosomal or IE gene responses (Kardalinou et al., 1994) , leaving the MAP kinases as the only signalling cascade currently indissociable from nucleosomal and gene induction events.
The prototypical MAP kinases ERK-1 and ERK-2 are de®ned by the motif TEY in the activation domain, within which threonine and tyrosine are phosphorylated by an upstream kinase MEK for activation (reviewed in Cooper, 1994; Cano and Mahadevan, 1995; Seger and Krebs, 1995) . The second subtype JNK/SAPKs, are characterised by the sequence TPY in the activation domain Kallunki et al., 1994; Kyriakis et al., 1994) , while the third, p38/ RK (p38, Han et al., 1994; CSBP, Lee et al., 1994; RK, Rouse et al., 1994; p40, Freshney et al., 1994; Mxi2, Zervos et al., 1995, referred to hereafter as p38/RK), has the motif TGY in this position. More recently, other variants of p38/RK, called SAPK3 (Mertens et al., 1996) and p38b (Jiang et al., 1996) have been identi®ed. These subtypes may be activated in parallel but to distinct extents by dierent stimuli (reviewed in Cooper, 1994; Cano and Mahadevan, 1995; Seger and Krebs, 1995) .
The three MAP kinase subtypes dier in their abilities to phosphorylate transcription factors, such as Ternary Complex Factor (TCF), c-Jun and ATF-2, which are strongly implicated in controlling c-fos and c-jun induction (reviewed in Cooper, 1994; Cano and Mahadevan, 1995; Seger and Krebs, 1995) . TCF, which together with serum response factor (SRF) occupies the c-fos serum response element (SRE), is phosphorylated by the ERKs; this is one route to activation of the c-fos gene (Gille et al., 1992; Marais et al., 1993; Zinck et al., 1993) . However, downstream kinases activated by ERKs (pp90 rsk /MAPKAP-K1) and p38/RK (MAP-KAP-K2), have also been implicated in c-fos induction via phosphorylation of SRF (Rivera et al., 1993) and CREB (Tan et al., 1996) . More recently, p38/RK has been shown to be essential for c-fos induction under conditions where the ERKs are not activated, such as upon anisomycin stimulation (Hazzalin et al., 1996) , possibly through the ability of this kinase to phosphorylate TCF (Price et al., 1996) .
The two AP-1 sites upstream of the c-jun gene are thought to bind homodimers or heterodimers comprising c-Jun and/or ATF-2 (van Dam et al., 1995) . Both c-Jun (Hibi et al., 1993; DeÂ rijard et al., 1994; Kallunki et al., 1994) and ATF-2 Livingstone et al., 1995; van Dam et al., 1995) bind to and are phosphorylated by the JNK/SAPK subtype of MAP kinases, and this mechanism, details of which is discussed in Dai et al. (1995) , is widely proposed to be the route by which stresses such as U.V. radiation ultimately activate the c-jun gene. However, we recently showed that these events are insucient, and that the p38/RK MAP kinase subtype is essential for anisomycin and U.V.-induced c-jun induction as well as for other nuclear responses such as histone H3 and HMG-14 phosphorylation (Hazzalin et al., 1996) . Although p38/RK has been shown to phosphorylate ATF-2 but not c-Jun in vitro , the ablation of p38/RK activity has no eect on anisomycin-or U.V.-stimulated ATF-2 phosphorylation (Hazzalin et al., 1996) . It is now clear that no single MAP kinase subtype is absolutely required for c-fos or c-jun induction , which may indicate that each subtype is capable, albeit to dierent extents, of phosphorylating the relevant transcription factors that control these genes. There may also be a requirement for multiple phosphorylation events mediated by distinct MAP kinase subtypes and/or their downstream kinases for the precise control of IE gene expression.
A potential complication of approaches used to de®ne these relationships is that they are often dependent on transfection-based protocols, using minimal regulatory elements which are modi®ed or multimerised to enhance the transcriptional response of reporter plasmids. Furthermore, the reporter plasmids are present at non-physiological copynumber, and are not properly folded into any higher-order structure resembling endogenous chromatin. Finally, the levels of expression of kinases or other signalling components introduced by transfection in these experiments may be suciently high to override any speci®city within the system. Endogenous IE genes are therefore almost certainly under more complex and subtle regulation than revealed by transfection-based approaches. Thus, it is important to verify in intact cells the kinase:transcription factor:IE gene relationships indicated by these approaches, an eort greatly boosted by the recent availability of speci®c inhibitors acting within the three MAP kinase cascades. These include PD 098059 which speci®cally blocks the activation of MEK and thereby the ERK cascade (Alessi et al., 1995) and SB 203580 which binds to and blocks the p38/RK MAP kinase subtype Cuenda et al., 1995) .
Here, we extend our recent analyses of the role of p38/RK in anisomycin-and stress-induced nuclear responses (Hazzalin et al., 1996) to examine the eects of the p38/RK inhibitor on the induction of ®ve IE genes, c-fos, fosB, c-jun junB and junD, under diverse conditions of stimulation. This represents the ®rst study where the eects of physiological (growth factors, cytokines), pharmacological (anisomycin, okadaic acid, TPA) and stress (U.V. radiation) stimuli on the activation of endogenous IE genes have been comprehensively analysed in the same cells, addressing the problem that much of the published work has been done using dierent cell lines and are not rigorously comparable. These studies demonstrate that p38/RK plays an important role in controlling levels of expression of all ®ve IE genes as a group in a similar way, and reveals a complexity to the relationship between MAP kinase subtypes and IE genes that is not apparent using other approaches.
Results
Much detailed background work has already been published on kinase cascades and immediate-early gene induction in the C3H 10T murine ®broblasts used here (Barratt et al., 1994a,b; Cano et al., 1994 Cano et al., , 1995 Cano et al., , 1996 Kardalinou et al., 1994; Hazzalin et al., 1996 and references therein) . Some of these ®ndings have been veri®ed in other mouse (NIH3T3, Swiss 3T3) and human (HeLa, Jurkat, MRC-5) cell lines (Cano et al., 1994 .
Diverse stimuli activate p38/RK and MAPKAP-K2
The activation characteristics of ERKs and JNK/ SAPKs under diverse conditions of stimulation in these cells have previously been described . Here, we have analysed activation of p38/RK (Figure 1a Figure 1a ) and MAPKAP-K2 (Figure 1b ) that were chromatographically indistiguishable. The elution pro®les for p38/RK and MAPKAP-K2 activity were similar to those obtained previously in PC12, A431, HeLa and KB cells (Rouse et al., 1994; Cuenda et al., 1995) . Using these assays, time-course analyses showed that EGF activates p38/RK ( Figure  1c ) and MAPKAP-K2 (Figure 1d ) very transiently, activity returning to basal levels within 15 min. The much weaker and more transient activation of this cascade by EGF in these cells is in accord with analyses of its upstream kinase MKK6 by chromatography (Hazzalin et al., 1996) and MAPKAP-K2 by in-gel kinase assays . In contrast, anisomycin and U.V. radiation produce very strong activation of this cascade, activity remaining detectable at 60 min (Figure 1c and d) . This level of activation is not usually observed with agents, such as growth factors. Identical assays using lysates from okadaic acid-stimulated cells revealed that this toxin activates the cascade more gradually, but to high levels (not shown). In contrast, TPA does not activate this pathway at all (data not shown; see also Figure 2a ), whereas TNF-a activates this cascade to levels similar to that of EGF (EC and LCM, not shown). Note that we consistently see some basal kinase activity at all three levels of this cascade in unstimulated C3H 10T cells (see Figure 2 ; data not shown and Hazzalin et al., 1996) . SB 203580 selectively blocks activation of MAPKAP-K2, has no eect on ERKs or JNK/SAPKs and causes a small increase in MKK6 activity Before using SB 203580 to examine the role of p38/RK in IE gene induction, we ®rst con®rmed its speci®city in C3H 10T cells (Figure 2a This property of SB 203580 to block p38/RK but augment the activation of its upstream kinase MKK6 is a novel observation, and may explain some of the eects this compound has on IE gene induction. By analogy with what is established for the ERK cascade, the augmented MKK6 activity in the presence of inhibitor may re¯ect ablation of negative-feedback in¯uences normally originating from downstream kinases.
To con®rm its speci®city, we also tested the eects of SB 203580 on ERKs and on JNK/SAPKs in C3H 10T cells. ERKs were assayed by Western blotting using either EGF or TPA as activators; SB 203580 had no eect on the activation of ERKs by either agent (Figure 2b ). Neither anisomycin nor okadaic acid activated ERKs in these cells (Figure 2b ). JNK/ SAPKs were assayed in cells stimulated with subinhibitory anisomycin to activate these kinases and show time course analysis of p38/RK and MAPKAP-K2 activation, performed by quantitating at each time-point the chromatographically resolved kinase activities corresponding to those shown in a and b respectively. Cells were stimulated for the times indicated with EGF, anisomycin or U.V. radiation exactly as described above for a and b. Total activities associated with the major peak of p38/RK and MAPKAP-K2 were quantitated as described using GST-c-Jun 1±79 as substrate. This showed that JNK/SAPK activation in response to EGF, anisomycin or U.V. irradiation was not inhibited in cells treated with SB 203580 (Figure 2c ), an observation that is con®rmed by direct analyses of the phosphorylation state of transcription factors which are substrates for these kinases. (Hazzalin et al., 1996) . Thus, in agreement with several recent studies, Gould et al., 1995; Beyaert et al., 1996) SB 203580 is extremely speci®c in C3H 10T cells, ablating p38/RK activation of MAPKAP-K2, but not aecting activation of the ERK or JNK/SAPK MAP kinase subtypes.
Dose-dependence of inhibition of dierent immediateearly genes by SB 203580
Preliminary analyses of the eects of ablating p38/RK activation by SB 203580 on c-fos and c-jun induction revealed strong inhibition of anisomycin-stimulated 7) ; SB 203580 (lane 4); or stimulated with EGF (50 ng/ml, 5 min; lanes 2 and 5); anisomycin (An; 50 ng/ml, 1 h; lanes 3 and 6); anisomycin (10 mg/ml, 30 min; lanes 10 and 11); U.V. radiation (U.V., 400 J/m 2 , 30 min; lanes 8 and 9). GST-c-Jun 1±79 binding kinases were then isolated as described in Materials and methods. After solid phase kinase assay, GST-c-Jun 1±79 proteins phosphorylated by bound kinase were analysed by SDS ± PAGE and autoradiography. The position of GST-c-Jun 1±79 on these gels, as determined by Coomassie Blue staining is indicated induction of these genes (Hazzalin et al., 1996 ; data not shown). The concentration-dependence of inhibition by SB 203580 of subinhibitory anisomycinstimulated induction of the mRNA encoding ®ve IE genes, c-fos, fosB, c-jun junB and junD was subsequently analysed (Figure 3 ). At very low inhibitor concentrations (0.1 mM), subinhibitory anisomycinstimulated induction of the c-fos gene was slightly inhibited while induction of the c-jun, junB and junD genes was not signi®cantly aected. At a concentration of 0.5 mM, inhibition of all IE genes begins to be observed. Maximal inhibition of the c-fos, c-jun, junB and junD gene induction responses was observed from a concentration of 1 ± 10 mM SB 203580 (Figure 3) , to extents similar to that seen with any higher concentration (20 mM; Figure 3 ). Note that induction of the fosB gene in response to anisomycin is generally extremely weak or undetectable. Inhibition of junD by SB 203580 is less apparent than that of c-fos, c-jun or junB; this may be due to the increased stability and persistence of these transcripts compared to that of the other IE genes studied here (Ryder et al., 1989 ; CAH and LCM not shown; see Figure 5 ). These results correlate well with the dose-dependence of inhibition of MAPKAP-K2 activation by SB 203580 in C3H 10T cells (Hazzalin et al., 1996; EC and LCM, unpublished data) . In experiments described below, SB 203580 was used at a concentration of 20 mM, at which we have found no non-speci®c eects on several kinases studied.
Eect of ablation of p38/RK activity on the induction of fos and jun genes by diverse stimuli Stimuli dierentially activating the three MAP kinase cascades were used to examine the inter-relationships between activation of MAP kinase subtypes and quantitative dierences in fos and jun gene expression. Anisomycin and U.V. radiation strongly activate JNK/SAPK and p38/RK MAP kinase subtypes; the latter has been shown to be essential for induction of c-fos and c-jun Hazzalin et al., 1996) . In C3H 10T cells EGF activates the ERK subtype strongly, and the JNK/SAPK and p38/RK MAP kinase subtypes to a lesser extent. TPA activates only ERKs and okadaic acid, like anisomycin, activates both JNK/SAPKs and p38/RK but not the ERKs (Cano et al., 1994 Hazzalin et al., 1996) . The eects of SB 203580 pretreatment on fos and jun gene induction responses to a broad range of agents were analysed at the point of optimal mRNA accumulation for each agent as previously determined by more detailed time-course analysis (CAH and LCM, not shown). These analyses reveal three types (I ± III below) of SB 203580 eects on IE gene induction.
I. SB 203580 does not signi®cantly alter induction of immediate-early genes in response to okadaic acid or TNF-a With the exception of fosB, which it induces very strongly, okadaic acid induces all these genes to levels similar to that seen in EGF-treated cells ( Figure  4 ). Okadaic acid induction of all these genes was either unaected or very slightly enhanced (e.g. fosB, Figure  4 ) by SB 203580 treatment. Thus, although p38/RK is very strongly active in okadaic acid-treated cells, its inhibition by SB 203580 has negligible eects on these nuclear responses. We have shown that the activation of MAPKAP-K2 by okadaic acid is also abolished as a consequence of p38/RK inhibition by SB 203580. However, the fact that nuclear responses persist could conceivably be because okadaic acid may act by inhibiting phosphatases regulating signalling steps downstream of these events or even in the nucleus, and thereby continue to activate IE gene induction in the absence of p38/RK activation. TNF-a is one of the agents that are reported to strongly activate JNK/SAPKs and p38/RK, and both these kinases have been implicated in mediating the nuclear eects of TNF-a (SaÂ nchez et al., 1994; Bayaert et al., 1996) . We found that TNF-a induces c-fos weakly, but does not induce fosB (Figure 4 , note dierence in scale for fosB). All three jun genes are activated by TNF-a, although in all cases activation is weaker than by EGF. We found, somewhat surprisingly given the prominence of reports in the literature about the role of p38/RK in TNF-a-induced nuclear responses, that induction of all these genes by TNF-a was not aected by the inhibition of p38/RK ( Figure  4 ).
II. General inhibition of all anisomycin-and U.V. radiation-stimulated IE gene induction responses by SB 203580 Anisomycin is an extremely potent inducer of c-jun and junD, and is a moderately strong inducer of c-fos and junB (Figure 4 ). In contrast, fosB is very weakly induced by anisomycin alone. Despite very strongly activating JNK/SAPK and p38/RK MAP kinase subtypes in C3H 10T cells, U.V. radiation is a relatively poor activator of fos and jun genes Hazzalin et al., 1996) , and does not signi®cantly induce fosB. SB 203580 strongly inhibited anisomycin-and U.V.-stimulated induction of c-fos, cjun, junB and junD (Figure 4) . Induction of c-fos, c-jun and junB by anisomycin were most sensitive to SB 203580 treatment and were inhibited 95%, 80% and 85% respectively, whereas junD induction was inhibited by 65% (Figure 4) . Apart from induction of junD which was not inhibited, U.V.-stimulated induction of the other genes was inhibited to a similar extent by SB 203580 treatment. The inhibition of c-fos, c-jun and junB induction correlated well with the inhibition of the p38/RK and downstream kinase MAPKAP-K2 observed under these conditions (Hazzalin et al., 1996) . We have previously shown that neither JNK/SAPK activation nor phosphorylation of the transcription factors c-Jun and ATF-2 are aected by SB 203580 under these conditions. This suggests that speci®c phosphorylation events, the identities of which are currently unknown, mediated by p38/RK and/or its downstream kinases are essential for the induction of all these genes by U.V. or anisomycin.
III. Enhancement of EGF-and TPA-stimulated induction of fos and jun genes in the presence of SB 203580 SB 203580 did not inhibit induction of c-fos, fosB, c-jun, junB and junD mRNAs in response to EGF. In fact, the presence of the inhibitor enhanced EGF-induced accumulation of these transcripts, particularly strong enhancement being seen for c-fos and c-jun transcripts (Figure 4 ). This eect is examined below over a more Figure 4 Dierential eects of SB 203580 treatment on the induction of fos and jun genes by speci®c stimuli. C3H 10T cells incubated in the absence (®lled columns), or presence (hatched columns), of SB 203580 (20 mM) for 15 min, were then stimulated with EGF (50 ng/ml, 30 min), TPA (100 nM, 45 min), TNF-a (5 ng/ml, 30 min), subinhibitory anisomycin (sAn; 25 ng/ml, 45 min) U.V. radiation (U.V.; 200 J/m 2 , 45 min) or okadaic acid (OA; 500 nM, 2 h). Control, unstimulated cells (con) incubated in the presence of SB 203580 were treated for 60 min. The speci®c times of stimulation with each agent were selected to enable detection of all gene induction responses at a single timepoint. It should be noted that induction of junD in response to TNF-a and U.V. radiation is not maximal at the time-point shown here. Following Northern blot analysis of c-fos, fosB, cjun, junB and junD gene expression, autoradiographs were subject to densitometric analysis and the absorbance values corrected for variations in loading using GAPDH. The graphs of the induction responses are presented on dierent scales for each gene, as determined by the absorbance value of the maximal response. Data presented here, particularly that relating to the inhibition or lack of eect produced by SB 203580, is stable and reproducible; the only slight variation observed through several experiments has been in the extent of augmented response seen in TPA-stimulated cells extended time-course, speci®cally to determine if the increase mRNA levels were persistent, as in superinduction (Edwards and Mahadevan, 1992) , and whether it was due to mRNA stabilisation ( Figure 5 ).
With TPA, we found the increase in the levels of transcripts caused by SB 203580 to be restricted to certain gene products. In particular, TPA-induced c-fos transcripts accumulated to higher levels in the presence of SB 203580. This was observed at 30 to 45 min, but by 60 min mRNA levels had returned to background (data not shown, see also Figure 5 ). In the presence of SB 203580, TPA-induced fosB and junD transcript levels were increased at 30 ± 45 min, while junB mRNA levels were only increased at 45 min (Figure 4 ; data not shown). In contrast, TPA-stimulated induction of c-jun was not signi®cantly aected by SB 203580 (Figure 4) . Note that although TPA does not activate the p38/RK kinase, the presence of SB 203580 causes an increase in the activity of its upstream kinase MKK6 in control, EGF-and TPA-stimulated cells (see Figure 2 ; data not shown). By utilising downstream pathways other than p38/RK, the enhanced MKK6 activity may cause the enhanced transcript levels seen here.
Analysis of mRNA stability in SB 203580-treated EGFstimulated cells
Alternatively the results maybe explained by suppresion of basil MAPKAP-K2 activity. The eect of SB 203580 on accumulation and persistence of EGFinduced fos and jun transcripts was examined over an extended time-course (30 min to 2 h; Figure 5 ). Pretreatment with SB 203580 resulted in increased levels of EGF-induced c-fos transcripts being detected at 30 min (2.8-fold) and 45 min (10.7-fold). EGFinduced c-fos transcripts were normally undetectable by 60 min, but in SB 203580-treated cells slightly elevated levels remained detectable at this time-point. Similarly, the elevated levels of fosB, c-jun and junB transcripts in cells treated with SB 203580 was transient, and not sustained as seen during superinduction (Edwards and Mahadevan, 1992) . Increased c-jun and junB mRNA levels were detected from 30 ± 60 min and fosB up to 90 min after which transcript levels rapidly declined. In SB 203580-treated cells, the maximal increase in c-jun mRNA levels was 2.9-fold at 45 min, for fosB ®vefold at 75 ± 90 min and for junB 3.3-fold at 60 min ( Figure 5 ). EGF-induced junD transcripts were detectable up to 2 h, at a similar level to that seen after 30 min stimulation. Co-treatment with SB 203580 resulted in slightly higher junD mRNA accumulation and this approximately 1.5-fold increased level was maintained over the full timecourse analysed here; this is possibly due to the intrinsic stability of these transcripts compared to that of other IE genes (Ryder et al., 1989; CAH and LCM not shown) . Although elevated, the enhanced induction responses seen here were considerably lower than those observed under superinducing conditions with anisomycin (data not shown).
The above suggests that although elevated, the mRNA in SB 203580-treated EGF-stimulated cells is not stabilised and disappears rapidly from these cells. This was con®rmed by direct analysis of the rate of decay of EGF-induced transcripts in cells in which further transcription is blocked by DRB treatment and mRNA levels monitored over the next 15 min (exactly as described in Edwards and Mahadevan, 1992) . Under with EGF (50 ng/ml) for 30 min to 2 h, as indicated. c-fos, fosB, c-jun, junB and junD mRNA levels were determined by Northern blot analysis. Autoradiographs of Northern blots were subject to densitometric analysis and the absorbance values corrected for variations in loading using GAPDH. The graphs of the induction responses are presented on dierent scales for each gene, as determined by the absorbance value of the maximal response these conditions, the presence of SB 203580 did not substantially alter the rate of disappearance of fos and jun transcripts, in agreement with indications from the time-course analysis above (data not shown). Thus, in contrast to anisomycin-induced superinduction, where transcripts are stabilised and enhanced responses are sustained (up to 6 h; see Edwards and Mahadevan, 1992) , the increased mRNA levels seen in EGFstimulated SB 203580-treated cells were only transiently detected and were not due to transcript stabilisation.
Discussion

Selective activation of ERK, JNK/SAPK and p38/RK MAP kinase subtypes
The exact pro®le and relative activation of each of the three MAP kinase subtypes is characteristic for the various stimuli used, and fall broadly into three categories (Cano et al., 1994 . Of these, only TPA exclusively activates a single MAP kinase subtype, the ERKs and data not shown) . A second category, exempli®ed by anisomycin and okadaic acid, strongly activate JNK/SAPKs and p38/RK but do not activate ERKs . Finally, EGF and U.V. irradiation activate all three cascades, but to dierent extents, EGF activating ERKs quantitatively but JNK/SAPKs and p38/RK more weakly, whereas U.V. irradiation activates the latter two subtypes very strongly and the ERKs barely detectably  Figure 1 ). Thus far, we have found that the activation of JNK/SAPKs is indissociable from that of p38/RK, although there are clear quantitative and temporal dierences. For example, EGF-stimulated p38/RK activation peaks at 5 min and is undetectable at 15 min (Figure 2b ), whereas JNK/SAPK activation by this mitogen peaks at 15 min . The patterns of activation described above are in accord with the view that ERKs are activated by a separate chain of kinases, whereas JNK/SAPKs and p38/RK may have an upstream activator(s) in common, and hence be activated together. Three potential activators of p38/RK have been described, namely the MAP kinase kinase homologues MKK4/ SEK1, MKK3 and MKK6 (SaÂ nchez et al., 1994; DeÂ rijard et al., 1995; Cuenda et al., 1996; Raingeaud et al., 1996) . Current evidence indicates that MKK4/ SEK1, one of whose upstream activators may be MEKK1 (Yan et al., 1994; Lin et al., 1995) may be the physiological activator of JNK/SAPKs but not p38/ RK because expression of the MEKK1 in COS or HeLa cells triggers the activation of JNK/SAPKs but not p38/RK Lin et al., 1995) .
In contrast, MKK3 and MKK6 activate p38/RK but not JNK/SAPKs in vitro Zervos et al., 1995) . In PC12 cells exposed to U.V. radiation, anisomycin and other stresses, MKK3 and MKK4 are the only endogenous activators of p38/RK detected after chromatography of the extracts on Mono S (Stokoe et al., 1992; Cuenda et al., 1996) . However, in stressed or IL1-stimulated KB cells, in LPS-or TNF-a-stimulated THP1 monocytes and in U.V.-or anisomycin-stimulated C3H 10T ®broblasts, MKK6 is the major activator of p38/RK (Hazzalin et al., 1996) . Moreover, in recent transfection-based analyses, MKK6 appears to be more potent than MKK3 as an activator of p38/RK in intact cells because although transfected MKK3 will activate co-transfected over-expressed p38/RK, it only activates the endogenous enzyme very weakly, whereas transfected MKK6 is capable of activating the endogenous cellular enzyme eciently (Raingeaud et al., 1996) . Thus, in C3H 10T cells, MKK6 is likely to be the principal EGF, anisomycin-and U.V.-stimulated activator of p38/RK.
The role of p38/RK in the induction of IE genes by dierent stimuli Several lines of evidence (Cano et al., 1994 Hazzalin et al., 1996 ; this paper) based on the inhibitor approach used here reveals a more complex relationship between distinct MAP kinase subtypes and the immediate-early genes than indicated using more invasive transfection-based protocols. First, evidence presented here shows that p38/RK is clearly capable of playing an essential role in the delivery of signals for activation of every one of the genes studied here, for example, in their induction by anisomycin or U.V. radiation. There is at present no clear reason why p38/ RK is essential under these conditions, particularly as we have shown that the phosphorylation of two transcription factors, c-Jun and ATF-2, implicated in activating the c-jun gene are unaected in the presence of SB 203580 (Hazzalin et al., 1996) . There are two possible explanations. First, there may be other transcription factors whose phosphorylation by p38/ RK or its downstream kinases is essential for gene activation. For example in SKNMC cells, SB 203580 prevents activation of CREB by FGF and arsenite but not by the cAMP-elevating agent forskolin (Tan et al., 1996) . The compound also ablates stress-induced phosphorylation of the transcription factor CHOP/ GADD153 (Wang and Ron, 1996) . A second possibility is that over and above the transcription factor phosphorylation, there may be commom co-factors or co-activators whose activation via p38/RK is essential for the induction of all these genes. In this context, it is relevant that although SB 203580 prevents TNF-astimulated induction of IL-6 in L929 and HeLa cells, which is thought to be mediated via NF-kB activation (Bayaert et al., 1996) , it has no eect on TNF-a-induced dissociation of NF-kB from its inhibitor I-kB, or on TNF-a-induced phosphorylation of NF-kB subunits Rel-50 and Rel-65 or on their ability to translocate to the nucleus and bind to DNA (Bayaert et al., 1996) . However, SB 203580 does inhibit transcription of a CAT reporter gene driven by two NF-kB binding sites, suggesting that it exerts its eect by inhibiting the activation of a co-factor essential for NF-kB binding or transactivation (Bayaert et al., 1996) . Similarly, there may exist general co-activators of IE genes whose activation via p38/RK is essential in particular circumstances. Although this might explain why the SB 203580 eects described here are general depending on the stimulus and not speci®c to particular IE genes, it would raise the question of why such events are essential in the induction of these genes by some agents but not by others, given that the transactivation and polymerase II engagement mechanisms are likely to be conserved whatever the stimulus. Ultimately, these issues can only be resolved with the de®nition of the exact substrates whose phosphorylation by p38/RK and/or its downstream kinases is essential for anisomycin-and U.V.-stimulated IE gene induction.
Although essential for anisomycin-and U.V.-stimulated responses, we show that there are many instances, such as upon stimulation with EGF, okadaic acid or TNF-a, when even though p38/RK is clearly active, it is not rate-limiting for the induction of these genes. There are indications that p38/RK may play a role in moderating transcript levels, but it should be noted, considering the possibility that MKK6 may activate other SB 203580-insensitive routes to these genes, that the increased levels of transcripts seen here may arise from the enhanced MKK6 activity seen when p38/RK is inhibited (see Figure 2) , . It is worth noting that the SB 203580-enhanced transcript levels are only observed clearly in response to EGF or TPA, both agents that strongly activate ERKs, raising the possibility that the enhanced induction originates from some form of crosstalk that normally occurs between p38/RK and ERK cascades. Finally, although TNF-a clearly activates p38/RK, and it would appear that p38/RK plays a central role in other TNF-a-induced nuclear responses (Beyaert et al., 1996) , this kinase is not involved in rate-limiting TNFa-stimulated induction of the IE genes studied here.
Taken together with previous work on ERKs JNK/ SAPKs and p38/RK in IE gene induction, these studies reveal a considerable degree of complexity in the way that these three MAP kinase subtypes are connected to individual IE genes. Further, there are indications that endogenous IE genes may require more than one signal for their activation and for precise physiological control of their levels of expression (Robertson et al., 1995; Price et al., 1996) . The possibility that dierent MAP kinases may compete to phosphorylate the same transcription factors cannot be excluded. Thus, models of dedicated signalling circuits involving speci®c MAP kinase subtypes and transcription factors committed to controlling particular IE genes may be an oversimpli®cation of the complexity that holds in intact cells.
Materials and methods
Materials
For kinase assays following chromatography, the Xenopus homologue of p38/RK (XMpk2) expressed in E. coli as a Mal-E fusion protein and human MAPKAP kinase-2 (residues 46 ± 400) expressed in E. coli as a GST fusion protein were puri®ed as described (BenLevy et al., 1995) .
Culture and stimulation of C3H 10T cells C3H 10T mouse ®broblasts were cultured in Dulbecco's modi®ed Eagle's medium (DMEM) with 10% (v/v) foetal calf serum (FCS). Con¯uent cultures were quiesced by incubation for 12 ± 18 h in DMEM containing 0.5% (v/v) FCS. Cells were pretreated as indicated with the compound SB 203580 (0.1 ± 20 mM, gift from Drs John Lee and Peter Young at SmithKline Beecham), and then stimulated as indicated, with EGF (50 ng/ml; kindly provided by G Panayotou, Ludwig Institute for Cancer Research, London), TPA (100 nM; Sigma) anisomycin (10 mg/ml; Sigma) or okadaic acid (500 nM; Sigma). For U.V. irradiation quiescent cells in 3 ml of DMEM per 100 mm-diameter dish were exposed to U.V. at the doses indicated, using a Spectrolinker (XL-100-; Spectronics Corp). Medium was aspirated and cells harvested as described below at the indicated times after stimulation.
Preparation of cell extracts
C3H 10T cells were quiesced and stimulated as described above and lysed directly in 150 ml of lysis buer (20 mM Tris-HC1 pH 8.0, 0.27 M Sucrose, 1 mM EGTA, 1 mM EDTA, 1% TX-100, 20 mM sodium b-glycerophosphate, 25 mM NaF, 1 mM sodium vanadate, 2 mM microcystin-LR, 0.1% (v/v) 2-mercaptoethanol, 2.5 mM sodium pyrophosphate). The extract was centrifuged for 10 min at 12 000 r.p.m. to remove particulate material and the supernatants frozen in dry ice until use.
Ion exchange chromatography and protein kinase assays
Lysates from C3H 10 cells (0.3 mg protein) were chromatographed in a Pharmacia SMART system using 560.16 cm columns of Mono Q equilibrated in 50 mM Tris-HC1 pH 7.5, 1 mM EDTA, 1 mM EGTA, 0.1% (v/v) 2-mercaptoethanol, 5% (v/v) glycerol, 0.03% (m/v) Brij 35, 1 mM benzamidine, 0.3 mM sodium orthovanadate (Buer A), or 560.16 cm columns of Mono S equilibrated in 20 mM sodium b-glycerophosphate pH 7.4, 1.5 mM EGTA, 0.1% (v/v) 2-mercaptoethanol, 0.03% (m/v) Brij 35, 5% (v/v) glycerol, 1 mM benzamidine, 0.1 mM phenylmethylsulphonyl¯uoride (Buer B). After washing with 2 ml of equilibration buer, the columns were developed with 4 ml linear salt gradients to 0.7 M NaCl in Buer A (Mono Q) or 0.5 M NaC1 in Buer B (Mono S). The¯ow rate was 0.1 ml per min and fractions of 0.1 ml were collected and assayed for p38/RK (Mono Q) or MKK6 and MAPKAP kinase-2 (Mono S).
MAPKAP kinase-2 was assayed using the peptide substrate KKLNRTLSVA (Stokoe et al., 1992) and one unit of activity was that amount which catalysed the phosphorylation of 1 nanomole of substrate in one min.
p38/RK was measured by the activation of GST-MAPKAP kinase-2 (residues 46 ± 400). The assay was identical to that described previously (Rouse et al., 1994) except that PP2A-inactivated rabbit MAPKAP kinase-2 was replaced by the bacterially expressed GST-fusion protein (®nal concentration=0.4 mM). One unit of p38/RK was that amount which increased MAPKAP kinase-2 activity by one unit per min (Stokoe et al., 1992) . The p38/RK activator (MKK6) was assayed by the activation of MalE-Mpk2. The assay was identical to that described previously (Rouse et al., 1994) , except that p38/RK from unstimulated PC12 cells was replaced by the MalE fusion protein (0.4 mM). One unit of MKK6 was that amount which increased the activity of RK by one unit per min.
Solid-phase JNK/SAPK assay
Plasmids encoding GST and GST-c-Jun 1±79 fusion proteins (Hibi et al., 1993) were provided by M Karin (UCSF, San Diego). GST-fusion proteins were puri®ed by anity chromatography on GSH-agarose as described previously and quanti®ed by the BCA protein assay (Pierce). Kinase assays were performed using a modi®cation of the method described by Hibi et al. (1993) . Cells were harvested in 200 ml of buer A (25 mM HEPES pH 8.0, 0.3 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.1% TX-100, 20 mM sodium b-glycerophosphate, 0.1 mM sodium vanadate and protease inhibitors (Mahadevan and Edwards, 1991; . These lysates were rotated at 48C for 30 min and the extract cleared by centrifugation at 13 000 g for 10 min.
Cell extracts were diluted so that the ®nal concentration of buer was 20 mM HEPES pH 8.0, 75 mM NaCl, 2.5 mM MgCl 2 , 0.1 mM EDTA, 0.05% TX-100, 20 mM b-glycerophosphate, 0.1 mM sodium vanadate, with protease inhibitors and mixed with 10 ± 20 ml of GSHagarose suspension (Sigma), containing approximately 10 mg of GST-c-Jun 1-79 fusion protein or GST alone (control for nonspeci®c binding). The mixture was rotated at 48C overnight. After four washes in HEPES binding buer (HBIB) (20 mM HEPES pH 8.0, 25 mM MgCl 2 , 0.1 mM EDTA, 50 mM NaCl, 0.05% TX-100) and a ®nal wash in kinase buer (20 mM HEPES pH 8.0, 20 mM MgCl 2 , 20 mM sodium b-glycerophosphate, 0.1 mM sodium vanadate, 2 mM DTT), beads were resuspended in 30 ml of kinase buer containing 20 mM ATP and 3±5 mCi[g-32 P]ATP. After 30 ± 40 min at 258C, the reaction was terminated by washing with HBIB buer. Phosphorylated proteins were boiled in 30 ml 26SDS sample buer and resolved on 10% SDS-polyacrylamide gels, followed by autoradiography.
Northern blot analysis
C3H 10T cells were prepared as described above and stimulated as indicated. The fos and jun gene induction responses to the agents described were analysed at the point of optimal mRNA accumulation, selected to enable detection of all gene induction responses to that agent at a single time point. This was previously determined by more detailed time-course analyses (CAH and LCM, not shown). Total cellular RNA was isolated as described in Chomczynski and Sacchi (1987) . Aliquots containing 3 mg RNA were resolved on formaldehyde/agarose gels (Sambrook et al., 1989) except 0.41 M formaldehyde was used, as described in Chomczynski (1992) and transferred onto nylon membranes (Hybond-N + , Amersham); hybridisation was performed essentially as described in Church and Gilbert (1984) using 32 P-labelled DNA. A PstI/SalI fragment of v-fos (Curran et al., 1982) was used to detect c-fos mRNA. All other probes were derived from cDNA clones of fos and jun genes, which were generously provided by Rodrigo Bravo (Roche); a 1.7 kb fragment of fosB in pGEM-1 (Promega); an EcoRI/SacII fragment derived from the mouse c-jun pAH119 plasmid (Ryseck et al., 1988) ; a 1.8 kb fragment of junB in pBluescripts KS + (Stratagene); and a 1.5 kb fragment of junD in pBluescript KS + (Stratagene). The glyceraldehyde 3-phosphate dehydrogenase (GAPDH) probe was a 1 kb fragment of murine cDNA cloned in pBluescript KS 7 (Stratagene), kindly provided by DR Edwards. For quanti®cation of autoradiographs, densitometry was performed on a Molecular Dynamics instrument using Imagequant Version 3.3. Readings for each lane were corrected using the corresponding GAPDH reading to compensate for slight variations in loading.
Western blotting analysis
For analysis of ERKs, total lysates were prepared as described in Cano et al. (1995) . Proteins were electrophoresed on 14% minigels (861260.75 cm) and transferred overnight to polyvinylidene di¯uoride membranes (Immobilon-P Millipore), in transfer buer (12.5 mM Tris, 192 mM Glycine, 0.05% SDS, 20% methanol). Membranes were blocked with 5% Marvel in 20 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.05% Tween 20 (TBST) for 1 h, then probed with mouse monoclonal antibody recognising human, mouse and rat ERK-1 and -2 (Zymed), diluted 1:10000 in TBST for 1 h. Membranes were rinsed twice then washed 3 times for 5 min each in TBST. After washing, blots were incubated with sheep-anti-mouse antibody coupled to horseradish peroxidase (1:10 000 in TBST) for 1 h, washed as before and visualised using the Renaissance detection system (NEN).
Note added in proof
The cloning of a p38/RK-related enzyme, SAPK4, that is activated by cytokines and stress but is not sensitive to inhibition with SB 203580 has recently been reported (Goedert M, Craxton M, Cuenda A, Jakes R and Cohen P. 1997, EMBO Journal, 16, 3563 ± 3571. 
